Cardinal Health raises FY25 EPS guidance to $7.85-$8 amid specialty growth and acquisitions
Management raised fiscal 2025 EPS guidance to $7.85-$8, a $0.10 increase at the midpoint, reflecting strong Pharma performance and contributions from recent acquisitions. The company expects Q3 to be ...
Cardinal Health price target raised to $135 from $127 at Wells Fargo
Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $135 from $127 and keeps an Equal Weight rating on the shares following ...